Retraction notice [0.03%]
撤稿通知
Retraction of Publication
Therapeutic advances in cardiovascular disease. 2015 Aug;9(4):NP1. DOI:10.1177/1753944718787703 2015
Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy [0.03%]
心力衰竭中脑啡肽酶抑制的研究进展及地位
Srikanth Yandrapalli,Mohammed Hasan Khan,Yogita Rochlani et al.
Srikanth Yandrapalli et al.
Cardiovascular (CV) disease is a major cause of morbidity and mortality in the developing and the developed world. Mortality from CV disease had plateaued in the recent years raising concerning alarms about the sustained efficacy of availab...
Evaluation of the impact of body mass index on warfarin requirements in hospitalized patients [0.03%]
评估体重指数对住院患者华法林需求量的影响
Katie B Tellor,Steffany N Nguyen,Amanda C Bultas et al.
Katie B Tellor et al.
Background: Despite well established empiric dose adjustments for drug and disease-state interactions, the impact of body mass index (BM) on warfarin remains unclear. The objective of this study is to evaluate warfarin re...
Elena Conroy
Elena Conroy
Cystatin C and galectin-3 as therapeutic targets in heart failure [0.03%]
半胱氨酸蛋白酶抑制剂C和半乳糖凝集素-3作为心力衰竭治疗靶点的研究
Christos Zivlas,Filippos Triposkiadis,Stelios Psarras et al.
Christos Zivlas et al.
Alirocumab as add-on therapy to statins: current evidence and clinical potential [0.03%]
阿利珠单抗与他汀类药物联用治疗的现有证据和临床应用潜力
Johann Auer,Robert Berent
Johann Auer
Atherosclerotic cardiovascular diseases (ASCVDs) are associated with a substantial mortality, physical morbidity, and mental disability. Elevated plasma low-density lipoprotein cholesterol (LDL-C) levels play a major role in the pathophysio...
Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease [0.03%]
安那度胺和内源性大麻素系统：心血管疾病的一种有吸引力的治疗途径
Virna Margarita Martín Giménez,Sandra Edith Noriega,Diego Enrique Kassuha et al.
Virna Margarita Martín Giménez et al.
Cardiovascular disease is currently not adequately managed and has become one of the main causes of morbidity and mortality worldwide. Current therapies are inadequate in terms of preventing its progression. There are several limitations, s...
Rheolytic effects of left main mid-shaft/distal stenting: a computational flow dynamic analysis [0.03%]
左主干中段/远端支架植入的溶栓效应：基于计算流体动力学的分析
Gianluca Rigatelli,Marco Zuin,Fabio Dell&#x;Avvocata et al.
Gianluca Rigatelli et al.
Background The aim of this study was to evaluate the rheolytic effects of stenting a mid-shaft/distal left main coronary artery (LMCA) lesion with and without ostial coverage. Stenting of the LMCA has emerged as a valid alternative in place...
Polypill: an affordable strategy for cardiovascular disease prevention in low-medium-income countries [0.03%]
polo药丸：发展中国家心血管疾病预防的经济型策略
Patricio López-Jaramillo,Silvia González-Gómez,Diego Zarate-Bernal et al.
Patricio López-Jaramillo et al.
The simplification of fixed dose medications by using a single 'polypill' is an attractive strategy to improve adherence to medications which has shown benefit to cardiovascular risk factor control and cardiovascular disease prevention or d...
Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients [0.03%]
脑利钠肽酶抑制剂长期应用于心力衰竭患者对其认知功能的影响研究
Niel N Shah,Muhammad U Dogar,Parin N Shah et al.
Niel N Shah et al.